Our PNA Structural Analysis Services support biotechnology companies, pharmaceutical discovery teams, diagnostic developers, and academic laboratories that need more than routine peptide nucleic acid quality control. Because PNA is built on an uncharged pseudopeptide backbone, structural evaluation often has to address not only identity and purity, but also duplex formation, conformational behavior, mismatch response, and the effect of labels, linkers, PEG, or other modifications on target recognition.
Our platform combines sequence-aware study design, intact mass confirmation, chromatographic impurity profiling, thermal denaturation analysis, circular dichroism, and advanced structural investigation for selected projects. We help teams connect analytical readouts to practical development decisions, whether the next step is resynthesis, redesign, conjugation refinement, comparison with other chemistries, or progression into PNA screening & validation services, PNA synthesis services, or broader oligonucleotide characterization services.
When the expected mass looks correct but the construct still underperforms: A passed mass check does not rule out deletion species, incomplete deprotection, conjugation heterogeneity, or structure-dependent assay failure. We connect identity and impurity data to the actual experimental question rather than stopping at a single release metric.
When duplex formation is strong but selectivity is unclear: PNA programs often succeed or fail on mismatch placement, target context, and the thermal window used in the assay. We evaluate hybridization behavior, duplex stability, and sequence discrimination so teams can separate a weak design from a weak experimental setup.
When labels, PEG, or other payloads change structural behavior: Modified PNA can gain function while losing solubility, accessibility, or binding balance. Our studies assess how conjugation site, linker choice, and payload size affect conformation, chromatographic behavior, and hybridization performance, with natural extension into PNA PEGylation and PNA probe synthesis.
When advanced PNA formats require more than routine QC: Gamma-modified, backbone-tailored, or heavily functionalized PNA constructs may need orthogonal evidence on structure and stability before they can be trusted in screening or assay development. We design fit-for-purpose packages for modified and comparative studies.
When teams need faster go/no-go decisions: Many clients do not need isolated measurements; they need an interpretable conclusion on whether a material should be advanced, repurified, resynthesized, relabeled, or reformulated. Our reporting is structured to support research, procurement, and project review decisions with less ambiguity.
Our PNA structural analysis service is designed for organizations that need decision-ready structural evidence instead of disconnected test results. Projects can start from client-supplied materials, newly prepared sequences, or constructs generated through custom PNA oligonucleotide synthesis. We tailor method selection to the actual question being asked, from basic confirmation to higher-value conformation and duplex behavior studies.
By integrating orthogonal analytical methods with project-aware interpretation, we help reduce rework, shorten troubleshooting cycles, and improve confidence in the structural quality of research-use PNA materials.
This matrix helps teams match the structural question to the right analytical package so studies stay technically focused and commercially useful.
| Analytical Question | Primary Readout | Typical Methods | Best Suited Materials | Decision Supported |
| Is the intended PNA construct present? | Identity and expected molecular mass | Intact mass confirmation, LC-MS, high-resolution MS, MALDI-TOF where appropriate | Unmodified PNA, labeled PNA, conjugated constructs, client-supplied lots | Release, resynthesis, or further structural study |
| Are related species affecting performance? | Purity profile and impurity distribution | HPLC, UPLC, orthogonal chromatographic review | Screening lots, stored samples, difficult hydrophobic or modified materials | Repurification, batch comparison, or method optimization |
| Does the PNA form the expected duplex? | Hybridization behavior and structural match quality | Duplex assessment, comparative target studies, sequence-matched and mismatch panels | Probe candidates, clamps, antisense-style constructs, capture reagents | Target confirmation, redesign, or candidate prioritization |
| How stable is the duplex under assay-relevant conditions? | Thermal transition profile and comparative stability | UV-melting, denaturation studies, temperature-dependent structural comparison | PNA-DNA, PNA-RNA, and PNA-PNA systems | Assay window definition and sequence ranking |
| Has the modification changed conformation? | Conformational fingerprint and structure trend | Circular dichroism, condition comparison, advanced structural analysis for selected cases | Gamma-PNA, chiral PNA, linker-modified or payload-bearing constructs | Modification selection or architecture refinement |
| Is the conjugated construct structurally usable? | Architecture integrity and payload effect | Combined MS, chromatography, duplex and conformation review | Fluorescent, PEGylated, peptide-linked, or immobilization-ready PNA | Conjugation optimization or progression into assay work |
| Why did a previously promising construct fail? | Root-cause evidence tied to structure | Comparative impurity, stability, duplex, and conformation package | Stressed samples, reformulated lots, underperforming probes | Resynthesis, relabeling, reformulation, or project redirection |
Many PNA programs fail for structural reasons that are not obvious from a single QC result. The matrix below shows how we connect common project signals to practical structural analysis strategies.
| Project Situation | Likely Structural Concern | Recommended Analysis Package | Typical Output | Most Relevant Programs |
| Correct mass but weak target signal | Hidden related species, poor duplex window, or unfavorable conformation | Intact mass, impurity profiling, duplex assessment, thermal review | Evidence on whether the issue is material quality or sequence behavior | Probes, clamps, capture reagents |
| Strong binding but poor mismatch discrimination | Suboptimal target position or an overly stable duplex design | Comparative matched/mismatch duplex and thermal studies | Sequence ranking and redesign guidance | Variant detection, selective hybridization |
| Modified construct shows abnormal chromatography | Payload heterogeneity, linker effect, or hydrophobic interaction issues | Orthogonal chromatographic profiling plus mass confirmation | Structural explanation of peak complexity and purification options | Labeled and conjugated PNA |
| Thermal behavior changes after modification | Altered base stacking, duplex geometry, or steric interference | Thermal denaturation and conformation comparison | Comparative stability map for modified versus reference constructs | Gamma-PNA, PEGylated PNA, reporter-linked PNA |
| Storage or formulation causes performance loss | Degradation, aggregation, or structural drift over time | Lot comparison, impurity profiling, stress comparison, duplex check | Root-cause view of whether the issue is chemical or structural | Archived lots, reformulated materials |
| Surface-bound or immobilized format stops working | Attachment-site interference or poor target accessibility | Conjugate review, duplex evaluation, comparative architecture study | Recommendation on linker and presentation strategy | Capture systems, sensor platforms |
| Client needs data for cross-functional review | Structural uncertainty is blocking internal decisions | Integrated structural package with decision-focused interpretation | Report suitable for R&D, project, and sourcing teams | Outsourcing reviews, candidate progression |
This workflow reflects how research teams typically engage us for fit-for-purpose structural studies on peptide nucleic acid materials and related constructs.
We confirm the sequence, modification status, target type, sample origin, and the core decision the study needs to support. This step prevents generic testing and keeps the structural package aligned with your actual project risk.
A study plan is built around the technical question, such as identity confirmation, impurity investigation, duplex stability, or conformational change. Controls, comparison sets, and expected outputs are defined before execution begins.
Initial analytical review establishes the starting condition of the material through identity and quality-focused methods. This creates a clear baseline before deeper duplex, stability, or modification-related work is performed.
The agreed analytical package is executed using the most relevant combination of chromatographic, mass-based, thermal, and conformational methods. Orthogonal design helps clarify whether the observed issue is compositional, structural, or both.
Individual readouts are interpreted together rather than as isolated results. We assess how identity, impurity profile, duplex behavior, and conformational trends explain the material's actual research performance.
Final deliverables summarize what was confirmed, what remains a risk, and what action is most appropriate next. Recommendations may include resynthesis, repurification, redesign, target repositioning, or progression into downstream validation.
PNA structural analysis requires a different logic from standard DNA or RNA QC. Our approach is built for teams that need technically grounded interpretation tied to research outcomes, not just a collection of instrument outputs.
Our structural analysis workflows are designed for research-stage programs where reliable evidence on PNA architecture, duplex behavior, and modification effects is critical to project progression.
Whether you need intact mass confirmation for a newly prepared construct, a comparative impurity review for client-supplied materials, duplex stability analysis for a probe candidate, or a broader conformation-focused investigation for a modified PNA format, our team can build a structural study package aligned with your research goal. We work with biotech companies, pharmaceutical R&D groups, diagnostic developers, and academic laboratories to generate interpretable data that supports real project decisions. From first-pass confirmation through orthogonal troubleshooting and next-step guidance, our service is structured to make PNA structural analysis more useful for discovery and assay development. Contact us to discuss your sequence, sample type, or structural question.
A project may include study design, intact mass confirmation, purity profiling, duplex analysis, thermal stability evaluation, conformational review, and decision-focused interpretation.
Yes. We can work with client-supplied lots, archived materials, modified constructs, and underperforming samples when the main need is structural clarification.
Common methods include LC-MS, HPLC or UPLC, UV-melting studies, circular dichroism, and other orthogonal techniques selected according to the structural question.
Yes. Comparative studies are often used to assess how linkers, fluorophores, PEG, peptides, or backbone modifications affect structural behavior and usability.
Yes. We can compare matched and mismatch-containing targets and assess thermal behavior to support probe, clamp, and selective binding projects.
Loading ......
